Advertisement

Reactions Weekly

, Volume 1771, Issue 1, pp 50–50 | Cite as

Atezolizumab/pembrolizumab

Pneumonitis: case report
Case report
  • 20 Downloads

Reference

  1. Yamakawa H, et al. Nintedanib allows retreatment with atezolizumab of combined non-small cell lung cancer/idiopathic pulmonary fibrosis after atezolizumab-induced pneumonitis: A case report. BMC Pulmonary Medicine 19: 156, No. 1, 22 Aug 2019. Available from: URL: http://doi.org/10.1186/s12890-019-0920-9 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations